SEC Form 4 · accession 0001225208-19-003785
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mikael Dolsten
Officer — President R&D
Period of report
Feb 23, 2019
Accepted (ET)
Feb 26, 2019 · 8:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000078003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 23, 2019 | F | 54,568 | $42.96 | D | 310,078 | D | |
| Common Stock | holding | — | — | — | 1,625 | I | By Rule 16b-3 Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).
- F2Price is the closing price of Pfizer common stock on February 22, 2019